Gene · 5336
Papers3,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NADPH oxidase 2 inhibitor GSK2795039 exerts antiplatelet and antithrombotic activity. | Sci Rep | 2025 | 41102391 | PubTator, text mining | PubMed |
| Alzheimer's disease-associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell-derived microglia-like cells. | Alzheimers Dement | 2025 | 41066163 | PubTator, text mining | PubMed |
| Inhibitory Effects of 3-Deoxysappanchalcone on Factor Xa Activity, Platelet Aggregation, and Experimentally Induced Thrombosis. | Arch Pharm (Weinheim) | 2025 | 41042155 | PubTator, text mining | PubMed |
| The Use of Genetics and Immunology in the Diagnosis and Care of Advanced Coccidioidomycosis: Where Are We Going? | J Fungi (Basel) | 2025 | 41003210 | PubTator, text mining | PubMed |
| Characterisation of an allosteric site in PLCγ enzymes and implications for development of their specific inhibitors. | Biochem J | 2025 | 41002943 | PubTator, text mining | PubMed |
| Malignancy in Adults with Inborn Errors of Immunity: A Retrospective Single-Center Study. | J Clin Immunol | 2025 | 40993321 | PubTator, text mining | PubMed |
| gapTrick-structural characterization of protein-protein interactions using AlphaFold. | Bioinformatics | 2025 | 40985612 | PubTator, text mining | PubMed |
| In Silico Molecular Docking Analysis of Valproic Acid as an Inhibitor of Bruton's Tyrosine Kinase: Potential Drug Repurposing for Allergies. | Cureus | 2025 | 40984895 | PubTator, text mining | PubMed |
| The KRAS-G12D mutation drives venous thromboembolism (VTE) and colorectal cancer progression via MAPK/ERK signaling. | Transl Oncol | 2025 | 40972150 | PubTator, text mining | PubMed |
| NCRAD: Advancing Alzheimer's research through high-quality biospecimens and data. | Alzheimers Dement | 2025 | 40955474 | PubTator, text mining | PubMed |
| Harnessing natural killer cell-related genes for prognostic and therapeutic advances in lung adenocarcinoma: a predictive model for survival and immunotherapy outcomes. | Transl Cancer Res | 2025 | 40950687 | PubTator, text mining | PubMed |
| Identification of Key Gene Related to Matrisome in HBV-Associated Liver Cirrhosis via Bioinformatics Analysis. | Int J Hepatol | 2025 | 40901642 | PubTator, text mining | PubMed |
| Molecular Characteristics, Heterogeneity, Plasticity, and Cell of Origin of Neuroendocrine Bladder Cancer. | Cancer Heterog Plast | 2025 | 40893664 | PubTator, text mining | PubMed |
| Heterozygous variants in PLCG1 affect hearing, vision, cardiac, and immune function. | Elife | 2025 | 40862571 | PubTator, text mining | PubMed |
| Ms4a4a deficiency ameliorates plaque pathology in a mouse model of amyloid accumulation. | Alzheimers Dement | 2025 | 40843775 | PubTator, text mining | PubMed |
| Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential: JACC: CardioOncology Short-Form Primer. | JACC CardioOncol | 2025 | 40841104 | PubTator, text mining | PubMed |
| PLCγ2 controls neutrophil-like cell sensitivity through calcium oscillation and gates chemoattractant concentration range for chemotaxis. | Front Immunol | 2025 | 40821808 | PubTator, text mining | PubMed |
| The mechanism by which FGF23/FGFR-1 activates NOX2-ROS in vascular endothelial cells in the context of severe heat stroke-induced acute lung injury. | Burns Trauma | 2025 | 40821618 | PubTator, text mining | PubMed |
| Osteoclast precursor cell-derived Flot2 is a novel therapeutic target for bone loss diseases. | Pharmacol Res | 2025 | 40816424 | PubTator, text mining | PubMed |
| Biobank-scale genetic characterization of Alzheimer's disease and related dementias across diverse ancestries. | Nat Commun | 2025 | 40813364 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5336/papers?page=6